Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Spironolactone Safety in Dialysis Patients
This study has been suspended.
( personnel shortage )
Study NCT00328809 Information provided by State University of New York - Upstate Medical University
First Received: May 19, 2006 Last Updated: June 8, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
End Stage Renal Disease
Congestive Heart Failure
Additional conditions recognized in this trial
Heart Failure
Kidney Diseases
Kidney Failure, Chronic
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Kidney Failure
Renal Insufficiency
Renal Insufficiency, Chronic
Urologic Diseases
Interventions listed in this trial
spironolactone
More general drug interventions related to this trial
Aldosterone Antagonists
Cardiovascular Agents
Diuretics
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
State University of New York - Upstate Medical University
Back to top of Main Content
